Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our ...

Investors are always looking for growth in small-cap stocks like Strongbridge Biopharma plc (NASDAQ:SBBP), with a market cap of USD $236.88M. However, an important fact which most ignore is: how ...

Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks may provide us ...

Oppenheimer issued lofty price targets for the pair of healthcare stocks Penny stocks TherapeuticsMD Inc (NASDAQ:TXMD) and Strongbridge Biopharma (NASDAQ:SBBP) are higher today, after analysts set ...

Strongbridge Biopharma (SBBP) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2020. This widely-known consensus ...

Strongbridge Biopharma plcSBBP was a big mover last session, as the company saw its shares rise over 10% on the day. The move came after the company met its enrollment target of 90 patients in the ...

Investors certainly have to be happy with Strongbridge Biopharma plc SBBP and its short term performance. After all, the stock has jumped by 47.9% in the past 4 weeks, and it is also above its 20 Day ...

Strongbridge Biopharma (SBBP) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.36 per share a year ago. These ...

Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks may provide us ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Strongbridge Biopharma (SBBP) reports results for the quarter ended June 2020. While this widely-known consensus ...